对比阿尔法阻断剂管理对良性前列腺增生后的急性尿的影响:系统性审查和网络元分析
Yong Nam Gwon1, Jae Joon Park1, Won Jae Yang1
1Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University Medical College, Seoul, Republic of Korea.
Prostate international
|July 6, 2023
概括
这项研究比较了在良性前列腺激增症 (BPH) 中急性尿 (AUR) 的α-阻塞剂疗法. 阿尔富佐辛加上坦苏洛辛在没有导管的试验 (TWOC) 中显示出最高的成功率,为BPH治疗提供了指导.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 基于证据的医学 基于证据的医学
背景情况:
- 良性前列腺增生症 (BPH) 经常导致急性尿 (AUR).
- 阿尔法阻断剂通常用于管理BPH症状并改善结果,如没有导管的试验 (TWOC) 成功率.
- 优化α-阻断剂选择对于BPH患者有效的AUR管理至关重要.
研究的目的:
- 为了比较各种α-阻断剂疗法的疗效,在患有BPH二次性AUR的患者中.
- 确定最有效的α阻断剂策略,以提高TWOC的成功率.
- 为临床实践提供基于证据的建议,用于管理由于BPH引起的AUR.
主要方法:
- 在主要数据库 (PubMed/Medline,Embase,Cochrane Library) 进行了系统的文献搜索,截至2021年6月.
- 对13项随机对照试验进行了贝叶斯网络元分析,以比较不同阿尔法阻断剂疗法和安慰剂之间的TWOC成功率.
- 衡量的主要结果是AUR后成功TWOC的几率比率.
主要成果:
- 与安慰剂相比,阿尔福佐辛,西洛多辛,坦苏洛辛以及阿尔福佐辛加坦苏洛辛的组合显著增加了TWOC成功率.
- 与安慰剂相比,多克萨佐辛没有显著改善TWOC成功率.
- 阿尔富佐辛加坦苏洛辛的组合被列为最有效的治疗方案,其次是坦苏洛辛,西洛多辛和阿尔富佐辛.
结论:
- 阿尔法阻断剂治疗可以提高TWOC的成功率在BPH二次的AUR患者.
- 这些发现表明阿尔法阻断剂疗法的有效性优先顺序,阿尔富佐辛加坦苏洛辛是最有前途的.
- 这种分析有助于临床医生为与BPH相关的AUR患者选择最佳的药理干预措施.
相关概念视频
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
889
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
889
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
893
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
893
Urinary Tract Calculi III: Medical Management
9
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
9
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
931
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
931
Antihypertensive Drugs: Direct Renin Inhibitors
699
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
699
Urinary Tract Calculi V: Nursing Management
14
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
14


